Neuvivo Inc.

Neuvivo appoints Michael McGrath MD, PhD as Chief Executive Officer

Appointment follows 12-month interim tenure of scientific, regulatory and commercial achievements for Phase 3 trial preparation in ALS PALO ALTO,…